Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

NCT ID: NCT06644976

Last Updated: 2024-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-20

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoperosis Femoral Neck Fractures Anticoagulant Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

early surgery

femoral neck CRIF

Intervention Type PROCEDURE

femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

late surgery

femoral neck CRIF

Intervention Type PROCEDURE

femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

femoral neck CRIF

femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery

\-

Exclusion Criteria

* under 18 y.o
* anti platelet therapy (aspirin is not included)
* creatinine clearance under 50
* active anti cancer therapy
* ITP patients
* non capable of making inform consent
* patients which decide not to proceed with the expeirment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meir Hospital, Kfar Saba, Israel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maron Talmore

Dr. meron pinchas talmor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Meir Hospital

Kfar Saba, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Meron pinchas talmor, medical doctor

Role: CONTACT

+972523264183

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Meron talmor, medical doctor

Role: primary

+972523264183

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mmc000723

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.